Printer Friendly

CURRENT TECHNOLOGY ANNOUNCES PRIVATE PLACEMENT FINANCING WITH CANACCORD

 VANCOUVER, British Columbia, March 24 /PRNewswire/ -- Current Technology Corporation (NASDAQ: CRTC-F) reports that it will seek private placement financing of up to $3,000,000 (U.S.). The financing will be for 1.5 million units at a price of $2.00 per unit. Each unit will consist of one common share and one share purchase warrant. Unit holders will be granted the opportunity to purchase an additional common share for $2.25 per share. The warrants have an expiration date of March 16, 1994, and the warrants will not be called for trading.
 The offering is being made available only to institutional investors in Europe by Canaccord Capital Corporation. Canaccord's fee (payable in Units at Canaccord's option) will be equal to 7.5 percent of the proceeds raised. Canaccord will also receive 100,000 broker warrants with an exercise price of $2.25 per share expiring on Sept. 16, 1993.
 The company also reports it has agreed to extend the expiration date on its Class A Series III, Class A Series IV and Class C Series warrants to Dec. 5, 1993, from March 17, 1993. The exercise price of the Class A Series III and IV warrants has been increased to $3.30 per share from $3.00 per share. Holders of the Class A warrants also hold Class B warrants which expire in December 1993 as well. If exercised, the Class A, B, and C warrants could net the company approximately $6,350,000.
 Current Technology Corporation is the developer of "ElectroTrichoGenesis" or ETG Therapy, a treatment for common baldness. The ETG Therapy device recently completed Phase III clinical trials in males.
 -0- 3/24/93
 /CONTACT: Robert K. Kramer, CFO, Current Technology Corporation, 604-684-2727; or Tom Laughran/Gale Strenger, 708-564-5610, Mark Perlgut, 212-874-6800, or Earle Brown, 813-796-1452, all of The Investor Relations Company, for Current Technology Corporation/
 (CRTC)


CO: Current Technology Corporation ST: British Columbia IN: MTC SU: OFR

JG -- DE001 -- 8994 03/24/93 09:30 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 24, 1993
Words:331
Previous Article:COPIER STOCK FROM XEROX ALLOWS USERS TO PRODUCE DOCUMENT FOLDERS Two-Part Pocket Folders Provide Economical Method for Full-Color Imaging, Assembly
Next Article:FEDERAL-MOGUL DECLARES SECOND-QUARTER DIVIDEND
Topics:


Related Articles
RECEPTAGEN ENGAGES CANACCORD FOR $8-10 MILLION SPECIAL WARRANT PLACEMENT
Meridex Announces Financing.
Meridex Announces Financing - Bought Deal with Canaccord, Best Efforts and Non-Brokered Financing.
SouthernEra Diamonds Cancels Brokered Private Placement.
Canaccord Capital Inc. Shares Commence Trading on AIM.
CANACCORD CAPITAL INC. - Commencement of Trading on AIM.
Srinath Narayanan joins Canaccord Adams as a principal in its technology investment banking group.
Canaccord Adams expands commitment to Alternative Financings, building on firm's strength in North America.
Canaccord Adams Forms Dedicated M&A Unit Focusing on Growth Companies in Technology, Life Sciences and Consumer.
ONDINE BIOPHARMA CORPORATION - Private Placement.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters